Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies-Reference-Cited by-同舟云学术

Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies

Published:2012-09-05 Issue:22 Volume:86 Page:12283-12293
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Verma S.,Dimitrova M.,Munjal A.,Fontana J.,Crevar C. J.,Carter D. M.,Ross T. M.,Khurana S.,Golding H.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference55 articles.

1. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine;Baras;PLoS One,2008

2. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle;Bright;PLoS One,2008

3. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes;Chen;J. Infect. Dis.,2009

4. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1;Cornelissen;PLoS One,2010

5. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine;Corti;J. Clin. Invest.,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method for screening influenza neutralizing antibodies in crude human plasma and its derivatives using SPR;Heliyon;2023-05

2. Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination;Nature Communications;2022-08-08

3. Immunogenicity and cross-protective efficacy of recombinant H5HA1 protein of clade 2.3.2.1a highly pathogenic H5N1 avian influenza virus expressed in E.coli;Microbial Pathogenesis;2022-07

4. High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity;Exploration of Immunology;2022-03-16

5. SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women;eBioMedicine;2022-03